H. Lee Moffitt Cancer Center.
H. Lee Moffitt Cancer Center and Research Institute.
Clin J Oncol Nurs. 2020 Oct 1;24(5):489-494. doi: 10.1188/20.CJON.489-494.
Falls experienced by patients undergoing blood and marrow transplantation or treatment with cellular immunotherapy (BMT-CI) may result in injury or death. An algorithm was developed using the patient fall circumstances identified in a chart analysis from 2016.
This study aimed to determine if the Moffitt BMT-CI Orthostatic Vital Signs Algorithm could decrease inpatient falls.
A pre-/post-test program evaluation was conducted for one year pre- and postimplementation of the algorithm on newly admitted inpatients. Adherence rate of nurses using the algorithm was monitored.
Overall falls decreased from 5.38% to 3.44%, with zero falls or injuries related to orthostasis for newly admitted patients. Adherence of nurses using the algorithm increased from 60% to 93%. The fall rate has been sustained less than baseline with 100% adherence, and the algorithm has been adopted as standard of practice.
接受血液和骨髓移植或细胞免疫治疗（BMT-CI）的患者可能会经历跌倒，导致受伤或死亡。本研究使用 2016 年图表分析中确定的患者跌倒情况制定了一个算法。
本研究旨在确定 Moffitt BMT-CI 直立生命体征算法是否可以减少住院患者跌倒。
在算法实施前一年对新入院患者进行了预/后测试方案评估。监测了护士使用算法的依从率。
总体跌倒率从 5.38%降至 3.44%，新入院患者无跌倒或与直立相关的伤害。使用算法的护士依从率从 60%增加到 93%。跌倒率低于基线且 100%依从率维持不变，该算法已被采纳为标准实践。
